Related Experiment Videos
Combination of immunosuppressive drugs for organ transplantation
Annals of the New York Academy of Sciences
|November 30, 1993
Abstract:
Several novel immunosuppressive agents have been developed in recent years. They exhibited not only remarkable immunosuppressive potency but also side effects. They are still short of the final goal in terms of immunosuppression for organ transplantation. Combination treatment is more effective and safer to use, and it will prevail in the future.
Insights
Novel immunosuppressive drugs show potency but cause side effects, hindering organ transplant success. Combination therapy offers a safer, more effective future for immunosuppression in transplantation.
Area of Science:
- Immunology
- Pharmacology
- Transplantation Medicine
Background:
- Recent advancements have introduced novel immunosuppressive agents.
- These agents demonstrate significant immunosuppressive capabilities but are associated with notable side effects.
- Current single-agent therapies fall short of the ideal for achieving complete immunosuppression in organ transplantation.
Purpose of the Study:
- To review the efficacy and limitations of novel immunosuppressive agents.
- To explore the potential of combination treatments for organ transplantation.
Main Methods:
- Literature review of recent studies on immunosuppressive agents.
- Analysis of efficacy and side effect profiles.
- Evaluation of combination therapy strategies.
Main Results:
- Novel agents possess high immunosuppressive potency.
- Significant side effects limit the clinical utility of some agents.
- Combination treatments appear to enhance efficacy and safety.
Conclusions:
- Current immunosuppressive agents are insufficient for optimal organ transplantation outcomes.
- Combination therapy represents a promising and potentially superior approach for future immunosuppression strategies in transplantation.